Income Statement
Jun '15
Jun '16
Jun '17
Jun '18
Jun '19
Jun '20
Jun '21
Jun '22
Jun '23
Jun '24

Total Revenues

12,468

12,861

14,544

14,694

13,640

Total Revenues % Chg.

31.8%

3.2%

13.1%

1%

-7.2%

Cost of Goods Sold, Total

9,932

10,129

11,724

11,969

10,928

Gross Profit

2,536

2,732

2,820

2,725

2,712

Selling General & Admin Expenses, Total

1,371

1,279

1,271

1,244

1,254

R&D Expenses

97

100

96

101

106

Other Operating Expenses

-35

-83

-54

-8

78

Other Operating Expenses, Total

1,433

1,296

1,313

1,337

1,438

Operating Income

1,103

1,436

1,507

1,388

1,274

Interest Expense, Total

-207

-157

-159

-274

-364

Interest And Investment Income

22

14

24

31

38

Net Interest Expenses

-185

-143

-135

-243

-326

Income (Loss) On Equity Invest.

-14

19

-4

Currency Exchange Gains (Loss)

21

-4

-37

-24

-3

Other Non Operating Income (Expenses)

3

-1

-1

-3

EBT, Excl. Unusual Items

928

1,307

1,334

1,121

938

Restructuring Charges

-55

-94

-96

-111

-97

Merger & Related Restructuring Charges

-60

Impairment of Goodwill

Gain (Loss) On Sale Of Investments

Gain (Loss) On Sale Of Assets

215

Asset Writedown

-1

-1

-139

Other Unusual Items

-1

16

26

62

EBT, Incl. Unusual Items

811

1,212

1,115

1,251

903

Income Tax Expense

187

261

300

193

163

Earnings From Continuing Operations

624

951

815

1,058

740

Earnings Of Discontinued Operations

-8

Minority Interest

-4

-12

-10

-10

-10

Net Income

612

939

805

1,048

730

Preferred Dividend and Other Adjustments

2

3

7

3

Net Income to Common Incl Extra Items

612

937

802

1,041

727

Net Income to Common Excl. Extra Items

620

937

802

1,041

727

Total Shares Outstanding

1,561.8

1,535.3

1,487

1,457.1

1,444.3

Weighted Avg. Shares Outstanding

1,600

1,551

1,509

1,468

1,439

Weighted Avg. Shares Outstanding Dil

1,602

1,556

1,516

1,476

1,441

EPS

0.4

0.6

0.5

0.7

0.5

EPS Diluted

0.4

0.6

0.5

0.7

0.5

EBITDA

1,733

2,000

2,089

1,956

1,857

Effective Tax Rate

23.1%

21.5%

26.9%

15.4%

18.1%